Patients with Hodgkin Lymphoma that were carriers of both XPO5 AA/CC and TARBP2 TT/TC genotypes had the shortest disease free survival (p = 0.008) and overall survival (p = 0.008). This evidence concerns the gene TARBP2 and Hodgkins lymphoma.